70 results
Page 2 of 4
8-K
EX-99.1
pcovpd7lzwa
11 Aug 22
Agile Therapeutics Reports Second Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
hh403a 1kw19w
13 Jul 22
Agile Therapeutics Updates Second Quarter 2022 Guidance
5:20pm
424B4
k3hz02 x6u3qylrdjt
5 Jul 22
Prospectus supplement with pricing info
4:26pm
8-K
fcopxnysmruo4h9y16
24 May 22
Departure of Directors or Certain Officers
7:30am
8-K
EX-99.1
i9v8fyx0 k1
24 May 22
Departure of Directors or Certain Officers
7:30am
8-K
ibd1fkf
23 May 22
Departure of Directors or Certain Officers
8:00am
8-K
EX-99.1
x0eebvz45c4yncv
12 May 22
Agile Therapeutics Reports First Quarter 2022 Financial Results and Provides Corporate Update
4:10pm
8-K
pasqo6 h1
27 Apr 22
Agile Therapeutics Announces 1-FOR-40 Reverse Stock Split
7:21am
424B5
pby 5f31iqclomyhu
27 Apr 22
Prospectus supplement for primary offering
6:30am
8-K
EX-99.1
qjaez4wh69bgflsi1y
30 Mar 22
Agile Therapeutics Reports Fourth Quarter & Full Year 2021 Financial Results and Provides Corporate Update
4:19pm
424B5
acsb6n7
14 Mar 22
Prospectus supplement for primary offering
5:26pm
8-K
7asqxxhv5w mcwy0p
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
8-K
EX-99.1
2mctsc5yf
10 Jan 22
Entry into a Material Definitive Agreement
8:05am
424B5
5y3c 7bkij6f6soh
10 Jan 22
Prospectus supplement for primary offering
8:00am